Purchase Order 75N93023P01043
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Emulate Inc. for the trade-in of a Zoe Culture Module 2. The contract has a ceiling value of $180,800 and a completion date of September 16, 2024. Emulate Inc., a for-profit organization that develops organ-on-a-chip technology, has received prior contract and grant awards from various federal agencies,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $217,700.00 firm-fixed-price purchase order contract to Emulate Inc., doing business as Emulate, a small business organization. The contract is for upgrades to the existing Zoe Culture Module Systems. This contract supports NIAID's initiatives in areas such as personalized medicine, biosurveillance, infectious disease research, and alternatives to animal testing. Emulate Inc. has provided a wide range of...
- This federal contract award, valued at $73,050.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., a for-profit organization specializing in organ-on-a-chip technology. The award is for a Restricted Lab Service Program to provide four Zoe CM2 Culture Modules for Organ Chips. The contract is a Firm Fixed Price Purchase Order with a completion date of September 16, 2025. This award does not utilize a set-aside designation. Emulate Inc., also known...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract, valued at $205,554.00, is for an extended warranty and service agreement for Emulate's organ-on-a-chip technology, which models human biology for biomedical research. This requirement supports NIAID's Integrated...
- This is a firm-fixed-price purchase order award by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Emulate Inc., doing business as Emulate, a for-profit organization. The contract is a Total Small Business Set-Aside with a potential value of $204,922.00 and a completion date of March 19, 2024. The award is based on a combined synopsis/solicitation for Emulate Bio Organ-On-AChip reagent kits. Emulate's organ-on-a-chip...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the Department of Health and Human Services, to Emulate Inc. (doing business as Emulate) for a "Service Agreement for Zoe". The contract has a ceiling value of $19,096.00 and a period of performance through May 30, 2026. It was awarded on May 31, 2024 and was not set aside for any specific business category. Emulate is a biotechnology...
- This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...
- The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...
- This is a federal contract award from the U.S. Army Research, Development and Engineering Command (RDECOM) to Emulate Inc., a biotechnology company specializing in organ-on-chip technology. The $82,750.02 firm fixed-price purchase order is for the delivery of "LIVER HEALTHY QUAD #CULTURE KITS." Emulate, a for-profit organization based in Boston, Massachusetts, has a history of supplying advanced microphysiological systems and associated services to various federal agencies, primarily...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Emulate Inc., a for-profit small business organization. The contract, valued at $24,997.00, is for the delivery of biological kits and reagents, which are likely components of Emulate's organ-on-a-chip technology products used to model human biology. These products support the National Cancer Institute's initiatives in areas such as...
This firm fixed price purchase order for $144,800 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Emulate Inc., doing business as Emulate, for the delivery of four ZOE culture module updates from Configuration 1 to Configuration 2. No set-aside designation was used for this procurement. Place of performance will be Emulate's facilities in Boston, Massachusetts. Emulate is a for-profit organization that develops proprietary organ-on-a-chip technology to model human biology for biomedical research supporting various federal agencies, including the Department of Health and Human Services and Department of Defense. This award will provide updated culture modules to support infectious disease research at the National Institute of Allergy and Infectious Diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $144.8k | 8/7/23 |